Patents by Inventor Kenneth J. Piller
Kenneth J. Piller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170342426Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independant transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.Type: ApplicationFiled: August 7, 2017Publication date: November 30, 2017Inventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
-
Publication number: 20160024512Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independent transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.Type: ApplicationFiled: September 23, 2015Publication date: January 28, 2016Inventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
-
Patent number: 9175298Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independent transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.Type: GrantFiled: September 18, 2007Date of Patent: November 3, 2015Assignee: Monsanto Technology LLCInventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
-
Patent number: 7960610Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independent transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.Type: GrantFiled: September 18, 2007Date of Patent: June 14, 2011Assignee: Monsanto Technology LLCInventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
-
Patent number: 7858370Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independent transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.Type: GrantFiled: September 18, 2007Date of Patent: December 28, 2010Assignee: Monsanto Technology LLCInventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
-
Patent number: 7288694Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independant transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.Type: GrantFiled: July 5, 2002Date of Patent: October 30, 2007Assignee: Monsanto Technology LLCInventors: Toni Armstrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
-
Patent number: 7195917Abstract: Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase. 3-? hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing a RNA or protein product which suppresses the gibberellin biosynthetic pathway sequence, diverts substrates from the pathway or degrades pathway substrates or products. The sequence is preferably a copalyl diphosphate synthase sequence, a 3?-hydroxylase sequence, a 2-oxidase sequence, a phytoene synthase sequence, a C20-oxidase sequence, and a 2?,3?-hydroxylase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.Type: GrantFiled: March 27, 2003Date of Patent: March 27, 2007Assignee: Monsanto Technology LLCInventors: Sherri M. Brown, Tedd D. Elich, Gregory R. Heck, Ganesh M. Kishore, Eugene W. Logusch, Sherry J. Logusch, Kenneth J. Piller, Sudabathula Rao, Joel E. Ream, Scott R. Baerson
-
Patent number: 6723897Abstract: Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase, 3-&bgr; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing antisense RNA which suppresses the gibberellin biosynthetic pathway sequence. The antisense sequence is the complement of a copalyl diphosphate synthase sequence, a 3&bgr;-hydroxylase sequence, or a C20-oxidase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.Type: GrantFiled: August 10, 1999Date of Patent: April 20, 2004Assignee: Monsanto Technology, LLCInventors: Sherri M. Brown, Tedd D. Elich, Gregory R. Heck, Ganesh M. Kishore, Eugene W. Logusch, Sherry J. Logusch, Kenneth J. Piller, Sudabathula Rao, Joel E. Ream, Scott R. Baerson
-
Publication number: 20030233679Abstract: Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase. 3-&bgr; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing a RNA or protein product which suppresses the gibberellin biosynthetic pathway sequence, diverts substrates from the pathway or degrades pathway substrates or products. The sequence is preferably a copalyl diphosphate synthase sequence, a 3&bgr;-hydroxylase sequence, a 2-oxidase sequence, a phytoene synthase sequence, a C20-oxidase sequence, and a 2&bgr;,3&bgr;-hydroxylase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.Type: ApplicationFiled: March 27, 2003Publication date: December 18, 2003Applicant: Monsanto Technology LLC.Inventors: Sherri M. Brown, Tedd D. Elich, Gregory R. Heck, Ganesh M. Kishore, Eugene W. Logusch, Sherry J. Logusch, Kenneth J. Piller, Sudabathula Rao, Joel E. Ream, Scott R. Baerson
-
Publication number: 20030110532Abstract: The compositions and methods are provided that enhance the selection of transgenic plants having two T-DNA molecules integrated into a plant genome at different physical and genetic loci. The compositions are DNA constructs that comprise novel arrangements of T-DNA molecules containing genes of interest, positive selectable marker genes, and conditional lethal genes. The methods disclosed herein comprises transforming a plant cell to comprise the DNA constructs of the present invention, regenerating the plant cell into a plant and identifying independant transgene loci, where the selectable marker genes or transgenic elements can be segregated in the progeny.Type: ApplicationFiled: July 5, 2002Publication date: June 12, 2003Inventors: Toni Armostrong, Kenneth Barton, Laura J. Crow, Larry A. Gilbertson, Shihshieh Huang, Yong Huang, Brian J. Martinell, Michael W. Petersen, Kenneth J. Piller, Qi Wang, Xudong Ye
-
Publication number: 20020053095Abstract: Methods and materials are disclosed for the inhibition and control of gibberellic acid levels. In particular, nucleic acid sequences of copalyl diphosphate synthase, 3-&bgr; hydroxylase, and 2-oxidase and additional nucleic acid sequences are disclosed. Gibberellic acid levels may be inhibited or controlled by preparation of a chimeric expression construct capable of expressing a RNA or protein product which suppresses the gibberellin biosynthetic pathway sequence, diverts substrates from the pathway or degrades pathway substrates or products. The sequence is preferably a copalyl diphosphate synthase sequence, a 3&bgr;-hydroxylase sequence, a 2-oxidase sequence, a phytoene synthase sequence, a C20-oxidase sequence, and a 2&bgr;,3&bgr;-hydroxylase sequence. Administration of a complementing agent, preferably a gibberellin or gibberellin precursor or intermediate restores bioactivity.Type: ApplicationFiled: August 10, 1999Publication date: May 2, 2002Applicant: ARNOLD WHITE & DURKEEInventors: SHERRI M. BROWN, TEDD D. ELICH, GREGORY R. HECK, GANESH M. KISHORE, EUGENE W. LOGUSCH, SHERRY J. LOGUSCH, KENNETH J. PILLER, SUDABATHULA RAO, JOEL E. REAM